Santa Cruz Biotechnology

ACTR-I (C-5) | Santa Cruz Biotechnology

mouse monoclonal IgG2a; ACTR-I Antibody (C-5) is an IgG2a κ mouse monoclonal ACTR-I antibody (also designated ACTR-I antibody) that detects the ACTR-I protein of mouse, rat and human origin by WB, IP, IF and ELISA. ACTR-I Antibody (C-5) is available as both the non-conjugated anti-ACTR-I antibody form, as well as multiple conjugated forms of anti-ACTR-I antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. Members of the transforming growth factor b superfamily bind to a pair of transmembrane proteins, known as receptor types I and II, which contain serine/threonine kinases and associate to form a signaling complex. Activin has been shown to bind a heteromeric noncovalent complex, which consists of a type I receptor, ACTR-IA (also designated ACVRI and ALK-2) or ACTR-IB (also designated ALK-4 and SKR2), and a type II receptor, ACTR-IIA (also designated ACVR2A) or ACTR-IIB (also designated ACVR2B). Both receptor types are highly expressed in brain. The activin receptor family members are thought to mediate distinct effects on gene expression, cell differentiation, and morpho- genesis in a dose dependent fashion.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.